Skip to main content
. 2021 Mar 3;11:5107. doi: 10.1038/s41598-021-84492-3

Figure 3.

Figure 3

(A) In vivo biodistribution analysis of Lipo-EPI and Lipo-EPI-LOX in orthotropic xenograft mouse model of human TNBC at different time points (0, 1, 2 and 24 h post injections). (B) bioluminescence and fluorescence analysis of explanted organs (liver, spleen, lungs, heart, kidneys, tumors) to detect EPI localization. (C) Lipo-EPI and Lipo-EPI-LOX fluorescent signal quantification in tumor. (D) Lipo-EPI and Lipo-EPI-LOX fluorescent signal quantification in explanted organs.